Shillong Herald

Adult Growth Hormone Deficiency Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

 Breaking News
  • No posts were found

Adult Growth Hormone Deficiency Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

October 21
05:32 2021
Adult Growth Hormone Deficiency Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
DelveInsight Business Research LLP
DelveInsight’s, “Adult Growth Hormone Deficiency (AGHD) – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Adult Growth Hormone Deficiency (AGHD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

DelveInsight’s “Adult Growth Hormone Deficiency Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the Adult Growth Hormone Deficiency pipeline landscapes. It comprises Adult Growth Hormone Deficiency pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Adult Growth Hormone Deficiency therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Adult Growth Hormone Deficiency pipeline products.     

Some of the key takeaways of the Adult Growth Hormone Deficiency Pipeline Report  

  • Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as, Ascendis Pharma, Genexine, OPKO Health, etc., are developing therapies for the treatment of Adult Growth Hormone Deficiency.

  • Emerging therapies such as TransCon hGH, HyTropin (GX-H9), Somatrogon, are expected to have a significant impact on the Adult Growth Hormone Deficiency market in the coming years.

Get an overview of pipeline landscape @ Adult Growth Hormone Deficiency Clinical Trials Analysis 

Adult Growth Hormone Deficiency Overview

Adult-Onset Growth Hormone Deficiency (AGHD) is a medical condition that occurs when the body does not produce enough growth hormone. It stimulates the release of another hormone called insulin-like growth factor 1, which is produced mainly by the liver. Together, these hormones produce growth in childhood and, in adult life, have widespread metabolic effects throughout the body.

Adult Growth Hormone Deficiency Emerging Drugs

  • TransCon hGH: Ascendis Pharma

  • HyTropin (GX-H9): Genexine

  • Somatrogon: OPKO Health

For further information, refer to the detailed report @ Adult Growth Hormone Deficiency Pipeline Therapeutics 

Scope of Adult Growth Hormone Deficiency Pipeline Drug Insight    

  • Coverage: Global 

  • Major Players: Ascendis Pharma, Genexine, OPKO Health, and others.

  • Pipeline Therapies: TransCon hGH, HyTropin (GX-H9), Somatrogon, and others.

Table of Contents

1

Adult Growth Hormone Deficiency Report Introduction

2

Adult Growth Hormone Deficiency Executive Summary

3

Adult Growth Hormone Deficiency Overview

4

Adult Growth Hormone Deficiency- Analytical Perspective In-depth Commercial Assessment

5

Adult Growth Hormone Deficiency Pipeline Therapeutics

6

Adult Growth Hormone Deficiency Late Stage Products (Phase II/III)

7

Adult Growth Hormone Deficiency Mid Stage Products (Phase II)

8

Adult Growth Hormone Deficiency Early Stage Products (Phase I)

9

Adult Growth Hormone Deficiency Preclinical Stage Products

10

Adult Growth Hormone Deficiency Therapeutic Assessment

11

Adult Growth Hormone Deficiency Inactive Products

12

Company-University Collaborations (Licensing/Partnering) Analysis

13

Adult Growth Hormone Deficiency Key Companies

14

Adult Growth Hormone Deficiency Key Products

15

Adult Growth Hormone Deficiency Unmet Needs

16 

Adult Growth Hormone Deficiency Market Drivers and Barriers

17

Adult Growth Hormone Deficiency Future Perspectives and Conclusion

18

Adult Growth Hormone Deficiency Analyst Views

19

Appendix

20

About DelveInsight

Get a customized pipeline report @ Adult Growth Hormone Deficiency Drugs Pipeline Report 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles